Individuals Stopping Weight-Loss Medications Regain Pounds at a Quadrupled Rate Compared to People Using Diet and Exercise

Fresh analysis indicates that individuals who come off blockbuster weight-loss injections like Mounjaro or Wegovy can put back on shed pounds far faster than those who halt conventional lifestyle programs.

Published data in a major medical journal demonstrates that while overweight individuals frequently drop substantial amounts of their total mass while undergoing treatment, the mass returns at an average rate of nearly a kilo each month after stopping.

"People purchasing these medications must be aware of the danger of quick rebound weight gain when the treatment concludes," warns lead investigator Dr. Susan Jebb.

That rate of regain means a reversion to original weight in about one and a half years.

Weighing Treatments

The research, which reviewed 37 of studies involving thousands of participants, contrasted the outcomes of the injectable medications with older methods.

Researchers emphasize that individuals who lose weight through lifestyle changes alone usually have a more gradual creep back—perhaps 0.1 kg a month—after stopping.

Explaining the Quick Rebound

Experts propose the way of the jabs explains the amplified rebound.

These medications imitate a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.

"Artificially providing the hormone concentrations several times higher than the body's typical production may cause the system to generate a reduced amount of its endogenous hormone, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a dietetics expert.

"Withdrawal of this GLP-1 'fix' results in appetite is uncontrolled, making overeating a significant risk."

A Lifelong Issue?

Health authorities advise the jabs for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications.

Many experts argue that, given the high risk of relapse, the therapy is often ongoing.

This view is echoed by drug manufacturers, who state that the results "emphasize the long-term character of excess weight," similar to managing diseases like hypertension.

User Accounts

Users who have stopped the medication explain a intense return of appetite.

"It felt as if something activating and I was suddenly extremely hungry," described a patient.

The struggle is exacerbated if users have not established sustainable lifestyle or habit modifications during therapy.

Widespread Interest

Recent estimates suggest that millions of people in the UK have tried these injections in the last 12 months, with interest remaining high.

• Adoption is more common among females compared to males.
• The middle-aged demographic shows the highest level of interest.
• A large proportion access the drugs through private prescriptions rather than the NHS.

In conclusion, experts stress that while GLP-1 drugs are powerful tools for shedding pounds, they are not a permanent fix and lasting health benefits hinges on combined lifestyle support.